(Q38032507)

27 August 2017

title

The emerging role of amiodarone and dronedarone in Chagas disease (English)

1 reference

27 August 2017

0 references

1 reference

Gustavo Benaim

1

1 reference

27 August 2017

Alberto E Paniz Mondolfi

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

7 August 2012

1 reference

Nature Reviews Cardiology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

605-609

1 reference

Physician awareness of Chagas disease, USA.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Chagas disease: "the new HIV/AIDS of the Americas"

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Epidemiology of Chagas disease in non-endemic countries: the role of international migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Cardiac arrhythmias in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Chemotherapy of Chagas' disease: the how and the why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

"Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Specific chemotherapy of Chagas disease: controversies and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Amiodarone Inhibits Trypanosoma cruzi Infection and Promotes Cardiac Cell Recovery with Gap Junction and Cytoskeleton Reassembly In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Dronedarone: a new antiarrhythmic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Atrial fibrillation: Dronedarone and amiodarone-the safety versus efficacy debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

The unfinished public health agenda of chagas disease in the era of globalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Measuring the burden of neglected tropical diseases: the global burden of disease framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.108

Pathogenesis of Chagas disease: time to move on.

31 March 2020

1 reference

12 December 2020

Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis

1 reference

12 December 2020

Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy

1 reference

12 December 2020

Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.

1 reference

12 December 2020

10.1038/NRCARDIO.2012.108

Identifiers

DOI

1 reference

27 August 2017

1 reference